沃特世公司(NYSE:WAT)获券商平均评级为“适度买入”——MarketBeat
Waters Corporation (NYSE:WAT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
生物技术与制药领域的最新动态
Waters Corporation (NYSE:WAT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Can Agilent Technologies Inc. stock test all time highs - 2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - Newser
India could scale semiconductor manufacturing faster than expected, says Thermo Fisher leaders - ET Manufacturing
Why Waters Corporation stock remains undervalued - Gap Up & Free Fast Entry Momentum Trade Alerts - Newser
Will Waters Corporation (WAZ) stock announce a stock split - Options Play & Safe Capital Investment Plans - Newser
Morgan Stanley Initiates Coverage of Agilent Technologies (A) with Overweight Recommendation - Nasdaq
The electrogenicity of the Na+/K+-ATPase poses challenges for computation in highly active spiking cells
The primate Major Histocompatibility Complex as a case study of gene family evolution
Dominant spinal muscular atrophy linked mutations in the cargo binding domain of BICD2 result in altered interactomes and dynein hyperactivity
Dorsal hippocampus mediates light–tone associations in male mice
Agilent Technologies (NYSE:A) VP Sells $464,970.00 in Stock - MarketBeat
Thermo Fisher expands bioprocessing capabilities across Asia - Investing.com
Thermo Fisher (TMO) boosts Asia biopharma support with new and expanded design centers - Stock Titan
Genetic testing transformed her cancer care—and her family tree - Illumina
Hospitals challenge 340B rebate pilot program in Maine federal court
Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key P - PharmiWeb.com
Pentagon seeks to add WuXi AppTec to military list: report
New York judge revives Bristol Myers dispute over Celgene deal
Janux T-cell engager data sink stock, but analysts still see best-in-class potential
FDA issues draft guidance to reduce primate testing for certain antibodies